4//SEC Filing
LEUTZINGER KURT 4
Accession 0001209191-11-051683
CIK 0001301081other
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 4:10 PM ET
Size
5.2 KB
Accession
0001209191-11-051683
Insider Transaction Report
Form 4
Pharmasset IncVRUS
LEUTZINGER KURT
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2011-10-11+75,000→ 75,000 totalExercise: $83.52Exp: 2021-10-10→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Shares vest on the following schedule: 25% on the first anniversary of the grant and 6.25% quarterly thereafter.
Documents
Issuer
Pharmasset Inc
CIK 0001301081
Entity typeother
Related Parties
1- filerCIK 0001211704
Filing Metadata
- Form type
- 4
- Filed
- Oct 12, 8:00 PM ET
- Accepted
- Oct 13, 4:10 PM ET
- Size
- 5.2 KB